Swiss National Bank’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6M | Sell |
122,000
-1,100
| -0.9% | -$141K | 0.01% | 708 |
|
|
2025
Q1 | $10.9M | Sell |
123,100
-1,500
| -1% | -$133K | 0.01% | 855 |
|
|
2024
Q4 | $10.9M | Buy |
124,600
+8,400
| +7% | +$733K | 0.01% | 900 |
|
|
2024
Q3 | $10.7M | Buy |
116,200
+1,800
| +2% | +$167K | 0.01% | 902 |
|
|
2024
Q2 | $12.3M | Buy |
114,400
+400
| +0.4% | +$43.1K | 0.01% | 797 |
|
|
2024
Q1 | $10.8M | Buy |
114,000
+500
| +0.4% | +$47.4K | 0.01% | 877 |
|
|
2023
Q4 | $10.5M | Sell |
113,500
-19,400
| -15% | -$1.79M | 0.01% | 862 |
|
|
2023
Q3 | $6.67M | Buy |
132,900
+2,300
| +2% | +$116K | 0.01% | 1106 |
|
|
2023
Q2 | $8.25M | Buy |
130,600
+1,500
| +1% | +$94.8K | 0.01% | 1016 |
|
|
2023
Q1 | $5.81M | Sell |
129,100
-15,100
| -10% | -$679K | ﹤0.01% | 1161 |
|
|
2022
Q4 | $6.32M | Buy |
144,200
+2,900
| +2% | +$127K | ﹤0.01% | 1178 |
|
|
2022
Q3 | $9.31M | Buy |
141,300
+1,800
| +1% | +$119K | 0.01% | 916 |
|
|
2022
Q2 | $7.05M | Buy |
139,500
+7,400
| +6% | +$374K | ﹤0.01% | 1106 |
|
|
2022
Q1 | $8.44M | Buy |
132,100
+9,600
| +8% | +$613K | ﹤0.01% | 1109 |
|
|
2021
Q4 | $13.1M | Hold |
122,500
| – | – | 0.01% | 858 |
|
|
2021
Q3 | $12.6M | Buy |
122,500
+1,100
| +0.9% | +$113K | 0.01% | 882 |
|
|
2021
Q2 | $10.7M | Buy |
121,400
+400
| +0.3% | +$35.2K | 0.01% | 987 |
|
|
2021
Q1 | $11.8M | Buy |
121,000
+2,300
| +2% | +$224K | 0.01% | 904 |
|
|
2020
Q4 | $13.3M | Buy |
118,700
+2,000
| +2% | +$224K | 0.01% | 792 |
|
|
2020
Q3 | $10.8M | Buy |
116,700
+2,100
| +2% | +$195K | 0.01% | 778 |
|
|
2020
Q2 | $8.94M | Buy |
114,600
+23,900
| +26% | +$1.86M | 0.01% | 823 |
|
|
2020
Q1 | $5.3M | Buy |
90,700
+1,400
| +2% | +$81.9K | 0.01% | 904 |
|
|
2019
Q4 | $7.15M | Buy |
89,300
+1,900
| +2% | +$152K | 0.01% | 940 |
|
|
2019
Q3 | $6.42M | Buy |
87,400
+9,400
| +12% | +$691K | 0.01% | 957 |
|
|
2019
Q2 | $7.36M | Buy |
78,000
+4,900
| +7% | +$462K | 0.01% | 900 |
|
|
2019
Q1 | $5.85M | Buy |
73,100
+3,300
| +5% | +$264K | 0.01% | 991 |
|
|
2018
Q4 | $3.76M | Buy |
69,800
+1,300
| +2% | +$70.1K | ﹤0.01% | 1151 |
|
|
2018
Q3 | $5.35M | Hold |
68,500
| – | – | 0.01% | 1070 |
|
|
2018
Q2 | $4.35M | Buy |
68,500
+1,300
| +2% | +$82.5K | 0.01% | 1201 |
|
|
2018
Q1 | $6.16M | Buy |
67,200
+2,500
| +4% | +$229K | 0.01% | 928 |
|
|
2017
Q4 | $4.88M | Buy |
64,700
+13,500
| +26% | +$1.02M | 0.01% | 1076 |
|
|
2017
Q3 | $3.57M | Hold |
51,200
| – | – | ﹤0.01% | 1244 |
|
|
2017
Q2 | $2.59M | Buy |
51,200
+4,900
| +11% | +$248K | ﹤0.01% | 1416 |
|
|
2017
Q1 | $1.85M | Buy |
46,300
+5,000
| +12% | +$200K | ﹤0.01% | 1617 |
|
|
2016
Q4 | $1.16M | Buy |
41,300
+11,100
| +37% | +$311K | ﹤0.01% | 1936 |
|
|
2016
Q3 | $897K | Hold |
30,200
| – | – | ﹤0.01% | 2037 |
|
|
2016
Q2 | $612K | Hold |
30,200
| – | – | ﹤0.01% | 2244 |
|
|
2016
Q1 | $527K | Buy |
30,200
+16,000
| +113% | +$279K | ﹤0.01% | 2276 |
|
|
2015
Q4 | $374K | Buy |
+14,200
| New | +$374K | ﹤0.01% | 2398 |
|